S, N., B, R., TL, L., G, I., I, T., A, D., . . . A, G. (2025). Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management. Cancers, 17(17), . https://doi.org/10.3390/cancers17172726
Chicago Style (17th ed.) CitationS, Nardin, et al. "Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management." Cancers 17, no. 17 (2025). https://doi.org/10.3390/cancers17172726.
MLA (9th ed.) CitationS, Nardin, et al. "Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management." Cancers, vol. 17, no. 17, 2025, https://doi.org/10.3390/cancers17172726.
Warning: These citations may not always be 100% accurate.